Atlas Trials

A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

Clinical trial NCT02776891 · WITHDRAWN

Trial details

NCT number
NCT02776891
Sponsor
University of California, San Francisco
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, Large B-Cell, DiffuseBurkitt Lymphoma
Start date
2016-06-13
Primary completion
2018-04-09
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.